{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:25:09Z","timestamp":1785209109263,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.healun.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T22:20:35Z","timestamp":1441318835000},"page":"1570-1577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device"],"prefix":"10.1016","volume":"34","author":[{"given":"Alanna A.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Pekarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Wittersheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Raja","family":"Laskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2015.08.013_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajt.12023","article-title":"OPTN\/SRTR 2011 annual data: Heart","volume":"13","author":"Colvin-Adams","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2015.08.013_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2012.12.004","article-title":"Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients","volume":"32","author":"Kirklin","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.08.013_bib3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2015.08.013_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1527-5299.2005.04540.x","article-title":"Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study","volume":"11","author":"Long","year":"2005","journal-title":"Congest Heart Failure"},{"key":"10.1016\/j.healun.2015.08.013_bib5","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2015.08.013_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jacc.2009.12.052","article-title":"Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients","volume":"55","author":"Rogers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2015.08.013_bib7","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1161\/CIRCULATIONAHA.111.079301","article-title":"Should left ventricular assist device be standard of care for patients with refractory heart failure who are not transplantation candidates?","volume":"126","author":"Mehra","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2015.08.013_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2007.03.063","article-title":"Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial","volume":"50","author":"Rogers","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2015.08.013_bib9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.jacc.2013.05.089","article-title":"Major bleeding during HeartMate II support","volume":"62","author":"Bunte","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2015.08.013_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacc.2013.08.1656","article-title":"Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients","volume":"63","author":"Boyle","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2015.08.013_bib11","first-page":"234","article-title":"Should women receive left ventricular assist device support? findings from INTERMACS","volume":"5","author":"Hsich","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2015.08.013_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.healun.2010.12.009","article-title":"Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation","volume":"30","author":"Bogaev","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.08.013_bib13","unstructured":"INTERMACS Working Group. Manual of operations for the Interagency Registry for Mechanically Assisted Circulatory Support: adverse events criteria (version 3.0). http:\/\/www.uab.edu\/medicine\/intermacs\/appendices\/appendix-a\/. Accessed May 25, 2014."},{"key":"10.1016\/j.healun.2015.08.013_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.healun.2015.08.013_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.healun.2015.08.013_bib16","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.healun.2015.08.013_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/jhg.2013.40","article-title":"Pharmacogenetics of warfarin: challenges and opportunities","volume":"58","author":"Lee","year":"2013","journal-title":"J Hum Genet"},{"key":"10.1016\/j.healun.2015.08.013_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2015.08.013_bib19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial","volume":"293","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2015.08.013_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2015.08.013_bib21","first-page":"22","article-title":"Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA)","volume":"4","author":"Rose","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2015.08.013_bib22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2015.08.013_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2015.08.013_bib24","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2015.08.013_bib25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/jama.2012.3490","article-title":"Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation","volume":"307","author":"Tsadok","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2015.08.013_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study","volume":"376","author":"O\u05f3Donnell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2015.08.013_bib27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.106.656850","article-title":"Prehypertension and cardiovascular disease risk in the women\u05f3s health initiative","volume":"115","author":"Hsia","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2015.08.013_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/STROKEAHA.107.496588","article-title":"Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study","volume":"39","author":"Boden-Albala","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2015.08.013_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.0000108926.04022.0C","article-title":"Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey","volume":"109","author":"Ninomiya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2015.08.013_bib30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2015.08.013_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.30.4.736","article-title":"Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort","volume":"30","author":"Rosamond","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2015.08.013_bib32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/STROKEAHA.108.540781","article-title":"Sex differences in stroke epidemiology: a systematic review","volume":"40","author":"Appelros","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2015.08.013_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1525-1594.2009.00888.x","article-title":"Preservation of endothelium nitric oxide release by pulsatile flow cardiopulmonary bypass when compared with continuous flow","volume":"33","author":"Lanzarone","year":"2009","journal-title":"Artif Org"},{"key":"10.1016\/j.healun.2015.08.013_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/cs0990555","article-title":"Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans","volume":"99","author":"White","year":"2000","journal-title":"Clin Sci"},{"key":"10.1016\/j.healun.2015.08.013_bib35","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.healun.2014.08.013","article-title":"The effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with LVADs","volume":"33","author":"Cornwell","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.08.013_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.athoracsur.2013.07.069","article-title":"Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events","volume":"97","author":"Lampert","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2015.08.013_bib37","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2015.08.013_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.healun.2013.04.004","article-title":"HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial","volume":"32","author":"Slaughter","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.08.013_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249815013881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249815013881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:30:01Z","timestamp":1760949001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249815013881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1053249815013881"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2015.08.013","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}